Publication Date
10-1-2014
Journal
The Texas Heart Journal
DOI
10.14503/THIJ-13-3544
PMID
25425984
Publication Date(s)
October 2014
Language
English
PMCID
PMC4189353
PubMedCentral® Posted Date
9-1-2014
PubMedCentral® Full Text Version
Post-Print
Published Open-Access
yes
Keywords
Heart valve diseases/pathology, heart valve prosthesis implantation/instrumentation/methods/trends, surgical procedures, minimally invasive/methods, treatment outcome, tricuspid valve insufficiency, tricuspid valve stenosis/therapy
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Abstract
Bioprosthetic heart valves can degenerate and fail over time. Repeat surgery as a means of replacement increases morbidity and mortality rates, and some patients are not candidates for reoperation. A newer treatment, percutaneous transcatheter valve-in-valve implantation, might delay or substitute for invasive procedures. We present the case of a 51-year-old woman, a poor candidate for surgery who had prosthetic tricuspid valve degeneration and stenosis. We successfully performed valve-in-valve placement of a Melody® valve, using a procedure originally intended to treat pulmonary valve conduit obstruction or regurgitation. To our knowledge, this is among the first case reports to describe the use of the Melody pulmonary valve in transcatheter valve-in-valve replacement for prosthetic tricuspid stenosis that was otherwise not correctable. Additional data and longer follow-up periods are necessary to gain an understanding of ideal indications and selection of patients for the percutaneous transcatheter treatment of tricuspid valve stenosis.